Bioteque Statistics

Total Valuation

Bioteque has a market cap or net worth of TWD 8.28 billion. The enterprise value is 7.62 billion.

Market Cap	8.28B
Enterprise Value	7.62B

Important Dates

The next estimated earnings date is Friday, March 14, 2025.

Earnings Date	Mar 14, 2025
Ex-Dividend Date	Jul 30, 2024

Share Statistics

Bioteque has 69.30 million shares outstanding. The number of shares has decreased by -0.06% in one year.

Current Share Class	n/a
Shares Outstanding	69.30M
Shares Change (YoY)	-0.06%
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	3.84%
Owned by Institutions (%)	16.47%
Float	55.26M

Valuation Ratios

The trailing PE ratio is 16.67 and the forward PE ratio is 15.89.

PE Ratio	16.67
Forward PE	15.89
PS Ratio	3.97
PB Ratio	2.52
P/TBV Ratio	2.52
P/FCF Ratio	13.38
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.44, with an EV/FCF ratio of 12.31.

EV / Earnings	15.26
EV / Sales	3.65
EV / EBITDA	9.44
EV / EBIT	11.78
EV / FCF	12.31

Financial Position

The company has a current ratio of 3.88, with a Debt / Equity ratio of 0.24.

Current Ratio	3.88
Quick Ratio	3.26
Debt / Equity	0.24
Debt / EBITDA	0.97
Debt / FCF	1.26
Interest Coverage	64.45

Financial Efficiency

Return on equity (ROE) is 15.64% and return on invested capital (ROIC) is 10.02%.

Return on Equity (ROE)	15.64%
Return on Assets (ROA)	9.00%
Return on Capital (ROIC)	10.02%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.46
Inventory Turnover	4.08

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.68% in the last 52 weeks. The beta is 0.46, so Bioteque's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	+12.68%
50-Day Moving Average	124.76
200-Day Moving Average	127.84
Relative Strength Index (RSI)	29.88
Average Volume (20 Days)	190,171

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bioteque had revenue of TWD 2.09 billion and earned 499.22 million in profits. Earnings per share was 7.17.

Revenue	2.09B
Gross Profit	901.60M
Operating Income	646.94M
Pretax Income	635.02M
Net Income	499.22M
EBITDA	792.66M
EBIT	646.94M
Earnings Per Share (EPS)	7.17

Full Income Statement

Balance Sheet

The company has 1.44 billion in cash and 781.26 million in debt, giving a net cash position of 663.32 million or 9.57 per share.

Cash & Cash Equivalents	1.44B
Total Debt	781.26M
Net Cash	663.32M
Net Cash Per Share	9.57
Equity (Book Value)	3.29B
Book Value Per Share	47.45
Working Capital	1.52B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 712.26 million and capital expenditures -93.54 million, giving a free cash flow of 618.72 million.

Operating Cash Flow	712.26M
Capital Expenditures	-93.54M
Free Cash Flow	618.72M
FCF Per Share	8.93

Full Cash Flow Statement

Margins

Gross margin is 43.21%, with operating and profit margins of 31.00% and 23.92%.

Gross Margin	43.21%
Operating Margin	31.00%
Pretax Margin	30.43%
Profit Margin	23.92%
EBITDA Margin	37.99%
EBIT Margin	31.00%
FCF Margin	29.65%

Dividends & Yields

This stock pays an annual dividend of 4.50, which amounts to a dividend yield of 3.77%.

Dividend Per Share	4.50
Dividend Yield	3.77%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	62.47%
Buyback Yield	0.06%
Shareholder Yield	3.82%
Earnings Yield	6.00%
FCF Yield	7.47%

Dividend Details

Stock Splits

The last stock split was on August 20, 2015. It was a reverse split with a ratio of 0.8006917977.

Last Split Date	Aug 20, 2015
Split Type	Reverse
Split Ratio	0.8006917977

Scores

Bioteque has an Altman Z-Score of 6.22.

Altman Z-Score	6.22
Piotroski F-Score	n/a